Daniel J. Becker, Director at Principia Biopharma Inc. (PRNB), bought 155,200 shares at $33.98 ($5.2M) on 2019-10-29, disclosed to the SEC on 2019-10-30.
Open-market purchase of $5.2M PRNB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.41 | 68,404 | $2.3M | 44.0% |
| 2 | $33.41 | 68,404 | $2.3M | 44.0% |
| 3 | $33.98 | 9,196 | $312K | 6.0% |
| 4 | $33.98 | 9,196 | $312K | 6.0% |
| Total | $33.48 avg | 155,200 | $5.2M | 100% |
| Filing → |
| DAWN | BUY | 2021-06-01 | $80K | — | Filing → |
| PAND | BUY | 2020-11-23 | $6.0M | — | Filing → |
| PAND | BUY | 2020-11-19 | $867K | — | Filing → |